27 Feb, EOD - Indian

SENSEX 81287.19 (-1.17)

Nifty Midcap 100 59115.6 (-1.14)

Nifty IT 30603.85 (0.16)

Nifty Next 50 69710.9 (-1.30)

Nifty 50 25178.65 (-1.25)

Nifty Pharma 22952.35 (-1.50)

Nifty Bank 60529 (-1.08)

Nifty Smallcap 100 16928.9 (-1.10)

27 Feb, EOD - Global

NIKKEI 225 58850.27 (0.16)

HANG SENG 26630.54 (0.95)

S&P 6870.91 (-0.85)


You are Here : Home > Research

17-Feb-2026

Sharda Cropchem

Revenue growth to be in the range of 15-20% in FY2027


'

Sharda Cropchem hosted a conference call on January 30, 2026. In the conference call the company was represented by Mr R V Burna –CMD, Shailesh Mehendale-CFO and Jetkin Gudhka-Company Secretary.

Key takeaways of the call

The company had a robust performance driven by strong volume growth and an improved product mix, supported by accelerated product registration. The company expects the growth momentum to continue in Q4 FY ''26 and remain strong through FY ''27.

As of December 31 2025, the company’s total product registration stood at 3,004. Additionally, 1,076 applications for product registrations globally are in the approval stage. Registration wise European region 1,675, NAFTA, 321, LATAM, 760, RoW 248, total 3,004.

Pipeline is Europe- 698, NAFTA- 100, LATAM- 153, and rest of the world- 125. Total 1,076.

Global agrochemical market is showing signs of recovery, driven by revival in demand, complem...



Pleaselogin & subscribe to view the full report.

More Reports
  • Company Logo

    (05-Feb-2025)

    Castrol India

    Expects EBITDA margin of 22%-25% for CY25

  • Company Logo

    (10-Feb-2023)

    Deepak Nitrite

    Plans capex of about Rs 1500 crore for FY23 and FY24

  • Company Logo

    (09-Feb-2023)

    Mayur Uniquoters

    Targets revenue of Rs 1000 crore in FY24

  • Company Logo

    (31-Jan-2023)

    Tega industries

    Capex plan is US$ 30-32 million for next three years

  • Analyst Meet / AGM-Conference Call   (17-Feb-2026)

    Sharda Cropchem

    Revenue growth to be in the range of 15-20% in FY2027

  • Results-Analysis   (30-Jan-2026)

    Sharda Cropchem

    NP up 366% yoy to Rs 145.1 crore in Q3FY2026

  • Analyst Meet / AGM-Conference Call   (30-Jan-2026)

    Sharda Cropchem

    EBITDA margins to be around 18-20% in FY2026 and FY2027

  • Analyst Meet / AGM-Conference Call   (01-Nov-2025)

    Sharda Cropchem

    Expect H2FY26 to be better than H1FY26

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +